Literature DB >> 3382597

Counter-regulatory effects of combined ACE inhibition and calcium antagonism.

R Donnelly, H L Elliott, P A Meredith.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3382597      PMCID: PMC1387819          DOI: 10.1111/j.1365-2125.1988.tb03340.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  3 in total

1.  Converting-enzyme inhibition buffers the counter-regulatory response to acute administration of nicardipine.

Authors:  M Bellet; P Sassano; T Guyenne; P Corvol; J Menard
Journal:  Br J Clin Pharmacol       Date:  1987-10       Impact factor: 4.335

2.  Vascular and aldosterone responses to angiotensin II in normal humans: effects of nicardipine.

Authors:  F Pasanisi; H L Elliott; J L Reid
Journal:  J Cardiovasc Pharmacol       Date:  1985 Nov-Dec       Impact factor: 3.105

3.  Captopril modifies the hemodynamic and neuroendocrine responses to sodium nitroprusside in hypertensive patients.

Authors:  W A Clementi; N L Durst; J L McNay; T K Keeton
Journal:  Hypertension       Date:  1986-03       Impact factor: 10.190

  3 in total
  1 in total

Review 1.  Pharmacokinetic drug interactions with ACE inhibitors.

Authors:  H Shionoiri
Journal:  Clin Pharmacokinet       Date:  1993-07       Impact factor: 6.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.